Nevro (NVRO) (ISIN: US64157F1030)股票专题，提供今日Nevro(NVRO) (ISIN: US64157F1030)股票最新股价查询，实时市场行情，走势图表，及Nevro Corp.(NVRO) (ISIN: US64157F1030)股票的专业技术分析，投资者论坛，历史交易数据，最新消息和未来价格预测。 Nevro将于4天内发布季度财报 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of NYSE:NVRO opened at $5.74 on Wednesday. Nevro has a 52 week low of $3.16 and a 52 week high of $15.98. The company has a current ratio of 5.02, a quick ratio of 3.76 and a debt-to-equity ...

40 prospects, 9 tire kickers and 1 serious buyer, Globus Medical. Four years ago, Nevro was worth more than $5 billon. Globus is paying $250 million for Nevro, who, by the way, has about $290 million ...

MILWAUKEE, Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical.

Patients who prefer to move freely could use the comfortable, state-of-the-art cardiac monitoring device. It has demonstrated the same effectiveness and quality as existing hospital- or home-based ...

Nevro has a 1-year low of $3.16 and a 1-year high of $17.63. Institutional Trading of Nevro Hedge funds have recently made changes to their positions in the business.

Even at that price, however, Globus Medical, Inc. has, again, bought a great company and paid blue-light special prices for it. Globus Medical will acquire Nevro in an all-cash transaction. Both ...

Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market ...

On February 7, 2025, Nevro Corp was acquired by Globus Medical (NYSE:GMED) in an all-cash transaction valuing NVRO at $5.85 per share, representing a total equity value of approximately $250 million.